Your session is about to expire
← Back to Search
Bmab1200 vs Stelara for Plaque Psoriasis (STELLAR-2 Trial)
STELLAR-2 Trial Summary
This trial is testing a new medication for plaque psoriasis to see if it is better than the current standard of care.
STELLAR-2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSTELLAR-2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 4 trial • 43 Patients • NCT02187172STELLAR-2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Bmab1200
- Group 2: Stelara
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Frequently Asked Questions
What is the status of Bmab1200's FDA approval process?
"Bmab1200 has been found to be safe in multiple clinical trials, and thus it receives a safety score of 3."
Are patients being sought out for this type of research currently?
"That is correct. The online clinicaltrials.gov registry reveals that, as of 7/14/2022, this trial is still actively looking for participants. This trial was originally posted on 6/28/2022 and is searching for a total of 384 patients at 1 location."
Does the age limit for this research study make anyone ineligible?
"In order to be eligible for this study, applicants must be aged 18 to 80. There are currently 32 clinical trials underway for patients under 18 and 154 for those over 65."
What are the aims of this scientific research being conducted with human subjects?
"The goal of this trial, which will be monitored over roughly Baseline to Week 12, is to Severity Index. Secondary outcomes include Affected body surface area, PASI improvement, and Dermatology Life Quality Index scores."
Are there any limitations on the total number of participants for this trial?
"That is correct. The listing on clinicaltrials.gov verifies that this clinical trial is still recruiting patients. This trial was first posted on June 28th, 2022 and was edited on July 14th, 2022. Up to 384 patients can be enrolled from a single site."
Share this study with friends
Copy Link
Messenger